Allowing sales of gametes and body parts and offering incentives to increase provision have been some of the more controversial suggestions to narrow the gap between demand and supply. Drawing on Richard Titmuss’ work on blood, many have argued that financial incentives reduce supply by driving out altruistic donors as well as reducing the quality of the provided gametes and body parts and the decision-making surrounding their provision. This debate brings together leading experts to consider, in the light of evidence and argument, whether the taboo on payment for gametes and body parts remains crucial, and how this should influence our thinking about policy.

Monday, 11 October 2010 5:30pm Tea served from 5pm
The Wellcome Collection Conference Centre
183 Euston Rd, London, NW1 2BE ​

Speaking for the motion​
Professor Martin Wilkinson Associate Professor of Political Studies, University of Auckland

Seconder Dr Evan Harris Former Chair All-Party Parliamentary Kidney Group

Speaking against the motion ​
Professor Heather Widdows Professor of Global Ethics, University of Birmingham

Seconder Professor Sheila M. Bird Senior Scientist, MRC Biostatistics Unit, Cambridge

Chair Professor Theresa M. Marteau Professor of Health Psychology, Kings College London; Director of CSI Health

To be followed by refreshments

CSI Health is a collaboration between King’s College London, Queen Mary University of London and The London School of Economics. It is funded by a Strategic Award in Biomedical Ethics from The Wellcome Trust. This event is open to all and free to attend.  To book your place please email csihealthadmin@kcl.ac.uk